Skip to main content

Moderna says preliminary trial data shows its coronavirus vaccine is more than 94% effective, shares soar

By CNBC  
   November 16, 2020

Moderna said preliminary phase three trial data shows its coronavirus vaccine is more than 94% effective in preventing Covid-19. The company’s CEO, Stephane Bancel, called it a “game changer.” Shares of Moderna jumped in premarket trading.

Full story


Get the latest on healthcare leadership in your inbox.